Adastra Holdings Ltd Investor Overview
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Econ Corp Services DBA Investorideas.com: Cannabis 2.0 Is Really Here - New Distribution and R&D Bolster Extract Capabilities
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Phyto Extractions Inc.: Phyto Extractions Announces Health Canada R&D License Addendum
LANGLEY
, BC / ACCESSWIRE / April 22, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX) (Frankfurt:D2EP) ( Phyto Extractions or the Company) is pleased to announce that it has received its R&D license addendum in Adastra Labs Inc. that will permit some limited human testing by licensed researchers administering or distributing cannabis to human research subjects using cannabis obtained from a holder of a license for processing in the final form of cannabis.
R&D License
This R&D license addendum will permit the Company to conduct in-house human testing for taste of various cannabis products for assessment of taste, sights, smell, or touch of cannabis.